
"Our strategy remains intact as we invest prudently in our research, manufacturing plants and enriching of skill sets. We are on track on our goal to launch 8-10 new products every year across our pharma business segments in India."
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2H2OGT0
via
IFTTT
0 comments:
Post a Comment